Form D — Hexamer Therapeutics, Inc

0001797915-26-000002 · filed Sep 15, 2026

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry: Biotechnology
Exemptions: 06b
Reported offering amount: $2,500,000
Reported amount sold: $500,000
Minimum investment: $0
Investors: 2
Sales commission: $0
Finders' fees: $0

Issuer

Name: Hexamer Therapeutics, Inc
CIK: 1797915
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: —
Address: 2345 NE HOPKINS CT
PULLMAN, WA 99163
Phone: 509-715-9251

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Robert H Bogden · Executive Officer

Pullman, WA Find on LinkedIn ↗
Colin Collins · Director

Vancouver, A1 Find on LinkedIn ↗
Keith Miller · Director

Moscow, ID Find on LinkedIn ↗
R. Scott Blackley · Director

Leesburg, VT Find on LinkedIn ↗
Stephen Crawford · Director

Bronxville, NY Find on LinkedIn ↗
Brad Call · Director

Pullman, WA Find on LinkedIn ↗

View the original filing on SEC EDGAR ↗